Shopping Cart
Remove All
Your shopping cart is currently empty
AZD0233 is an orally active CX3CR1 antagonist that immunomodulates the CX3CR1/CX3CL1 signaling axis. It improves cardiac function in dilated cardiomyopathy mouse models while reducing macrophage infiltration and fibrotic scarring.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $373 | 8-10 weeks | 8-10 weeks | |
| 5 mg | $885 | 8-10 weeks | 8-10 weeks | |
| 10 mg | $1,190 | 8-10 weeks | 8-10 weeks | |
| 25 mg | $1,770 | 8-10 weeks | 8-10 weeks | |
| 50 mg | $2,380 | 8-10 weeks | 8-10 weeks |
| Description | AZD0233 is an orally active CX3CR1 antagonist that immunomodulates the CX3CR1/CX3CL1 signaling axis. It improves cardiac function in dilated cardiomyopathy mouse models while reducing macrophage infiltration and fibrotic scarring. |
| In vivo | AZD0233 can improve the cardiac function of mice with dilated cardiomyopathy and reduce macrophages and fibrotic scars[1]. |
| Molecular Weight | 456.54 |
| Formula | C19H29FN6O4S |
| Cas No. | 3036141-78-0 |
| Smiles | C([C@@H](C)C=1C(F)=CC(OC)=NC1)C=2N=C(N[C@H](CC(C)C)CO)N=C(NS(C)(=O)=O)N2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.